Correspondence to Professor Min Dai, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ...
Dr A K Burroughs, Liver Transplantation and Hepatobiliary Medicine, Royal Free Hospital, Pond Street, London NW3 2QG, UK. andrew.burroughs{at}talk21.com If you wish ...
2 Department of Gastroenterology, Academic Medical Centre, Amsterdam, The Netherlands Correspondence to Geert D'Haens, Department of Gastroenterology, Academic Medical Centre, Meibergdreef 9-C2-112, ...
Introduction: Background Patients admitted with decompensated chronic liver disease (DCLD) who recover from their immediate illness may experience delayed discharge on account of laboratory ...
We would like to offer some critical observations regarding the recent article published on the environmental impact of ...
Alcohol-associated hepatitis (AH) is the acute deterioration of alcohol-related liver disease (ArLD) with rapid onset or ...
The role of the human microbiome in GI disease is an area of significant clinical and academic interest. The microbiome may ...
Department of Medicine, Division of Digestive Diseases and Gastroenterology, UCLA Medical Centre and Beth Israel Deaconess Medical Centre, Los Angeles, California, USA Dr T Lembo, Beth Israel ...
Objective In acute pancreatitis (AP), bacterial translocation and subsequent infection of pancreatic necrosis are the main risk factors for severe disease and late death. Understanding how ...
Objectives Many cross-sectional surveys have reported the prevalence of uninvestigated dyspepsia, but there has been no recent systematic review of data from all studies to determine its global ...
Background Existing scales for assessing faecal incontinence have not been validated against clinical assessment, or with regard to reproducibility. They also fail to take into account faecal urgency, ...
Objective Dysregulated cellular metabolism is a distinct hallmark of human colorectal cancer (CRC). However, metabolic programme rewiring during tumour progression has yet to be fully understood.